Leonard S. Schleifer, M.D., Ph.D.
Leonard S. Schleifer, M.D., Ph.D. is the co-founder, President and Chief Executive Officer of Regeneron, one of the world’s most innovative biotechnology companies. Under his leadership, Regeneron has grown from a tiny startup into a ~$40 billion market cap company. Regeneron is known for its unique science-driven culture, which has produced an industry-leading drug discovery and development engine and seven entirely homegrown FDA-approved medicines. The company also has a robust pipeline of clinical-stage therapies for a wide range of serious diseases. Len has been recognized as one of Barron’s Best CEOs, and together with Regeneron CSO George Yancopoulos, M.D., Ph.D., as Ernst & Young’s Life Sciences Entrepreneurs of the Year and Yale School of Management Legends in Leadership. Len graduated Phi Beta Kappa and summa cum laude from Cornell University and was awarded his M.D. and Ph.D. in Pharmacology from the University of Virginia. He is a licensed physician, Board Certified in Neurology by the American Board of Psychology and Neurology, and an American Association for the Advancement of Science Fellow.
George D. Yancopoulos, M.D., Ph.D.
George D. Yancopoulos, M.D., Ph.D., is the co-founder, President and Chief Scientific Officer of Regeneron. George, together with key members of his team, is a principal inventor and developer of Regeneron’s seven FDA-approved medicines as well as its foundational drug discovery technologies. George is responsible for the science-driven, collaborative and highly-productive R&D culture at Regeneron. This culture has earned the company recognitions including repeatedly being named the number one company to work for in the biopharmaceutical industry by Science magazine and being named one of the top five most innovative companies in the world by Forbes magazine. George has also driven Regeneron’s commitment to STEM education, which includes robust internship and mentoring programs. He has spearheaded the company’s support for the Regeneron Westchester Science and Engineering Fair in New York’s Hudson Valley, the Regeneron Prize for Creative Innovation for top graduate and postdoctoral students, the Regeneron Science Talent Search and the Regeneron International Science and Engineering Fair. George attended the Bronx High School of Science and received his M.D. and Ph.D. from Columbia University. He was the 11th most highly cited scientist in the world in the 1990s, and in 2004, he was elected to be a member of the National Academy of Sciences. George has received numerous recognitions, including Ernst & Young’s Life Sciences Entrepreneurs of the Year and Yale School of Management Legends in Leadership, both alongside Regeneron CEO Len Schleifer.